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Abstract   
In tissue engineering bioreactors can be used to aid in the in vitro development of new 
tissue by providing biochemical and physical regulatory signals to cells and encouraging 
them to undergo differentiation and/or to produce extracellular matrix prior to in vivo 
implantation.   This study examined the effect of short term flow perfusion bioreactor culture, 
prior to long term static culture, on human osteoblast cell distribution and osteogenesis within 
a collagen glycosaminoglycan (CG) scaffold for bone tissue engineering. Human Foetal 
Osteoblasts (hFOB 1.19) were seeded onto CG scaffolds and pre-cultured for 6 days. 
Constructs were then placed into the bioreactor and exposed to 3x1hr bouts of steady flow 
(1ml/min) separated by 7hrs of no flow over a 24hr period. The constructs were then cultured 
under static osteogenic conditions for up to 28 days. Results show that the bioreactor and 
static culture control groups displayed similar cell numbers and metabolic activity. 
Histologically however, peripheral cell-encapsulation was observed in the static controls, 
whereas, improved migration and homogenous cell distribution was seen in the bioreactor 
groups. Gene expression analysis showed that all osteogenic markers investigated displayed 
greater levels of expression in the bioreactor groups compared to static controls. While static 
groups showed increased mineral deposition; mechanical testing revealed that there was no 
difference in the compressive modulus between bioreactor and static groups. In conclusion, a 
flow perfusion bioreactor improved construct homogeneity by preventing peripheral 
encapsulation whilst also providing an enhanced osteogenic phenotype over static controls.  
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Introduction 
Bioreactors have been used to improve cellular activities in many biotechnological and 
bioengineering processes from fermentation and drug production to organ regeneration and 
tissue engineering. Similarly, they have been used to aid in vitro tissue formation of several 
organs including cartilage, prostate, gut, heart and liver formation (Kim et al. 2007; Margolis 
et al. 1999; Syedain and Tranquillo 2009; Yates et al. 2007). Several types of bioreactors 
exist including spinner flasks, rotating wall vessels, hydrostatic, dynamic compression  and 
flow perfusion (Chowdhury et al. 2008; Elder and Athanasiou 2009; Frith et al. 2009; Jaasma 
and O'Brien 2008; Wang et al. 2009). They all aim to improve on traditional static culturing 
methods by providing a more efficient nutrient delivery and waste removal system under 
controlled settings. Disadvantages of long term static culture include the development of a 
cell capsule along the periphery of the construct which can cause limited nutrient and waste 
mass transfer resulting in central core degradation (Keogh et al. 2010; Keogh et al. 2009; 
Shea et al. 2000). Therefore, one objective of this study is to use a flow perfusion bioreactor 
to improve cell distribution within a collagen glycosaminoglycan (CG) scaffold in order to 
prevent peripheral encapsulation and subsequent core degradation developing during long 
term osteogenic culture.  
Flow perfusion bioreactors act by directing the flow of media through the interior of a cell 
seeded scaffold. Different versions of these bioreactors exist for bone tissue engineering and 
are often specifically developed for a given scaffold type e.g. for stiffer scaffolds such as a 
titanium mesh (Bancroft et al. 2002) or for compliant scaffolds such as the CG scaffold. Flow 
perfusion bioreactors have been previously shown to improve cell seeding and distribution 
within 3-dimensional constructs (Glowacki et al. 1998; Goldstein et al. 2001; Janssen et al. 
2006). In addition, they have also been shown to provide mechanical stimuli to cells which 
can be beneficial for improving cell activity and maturation (Owan et al. 1997; Zhu et al.), for 
example, osteoblasts are a highly mechanosensitive cell that have been shown to respond to 
fluid flow resulting in altered gene expression levels of the bone formation markers alkaline 
phosphatase, osteopontin and osteocalcin (Partap et al. 2009; Wiesmann et al. 2004). Thus, 
the second objective of this study was to investigate the effect of the application of flow on 
the long term effects on osteoblast behaviour in terms of gene expression and cell viability.  
Specifically, the hFOB 1.19 (human foetal osteoblast) cell line was chosen for the study 
(Harris et al. 1995). hFOB cells have been shown to undergo sequential osteogenesis by 
expressing high levels of routine bone formation markers and to mineralise in 2D and in 3D 
(Donahue et al. 2000; Harris et al. 1995). In a recent publication, we showed that the CG 
scaffolds supported the attachment, infiltration and viability of human osteoblast cells (hFOB 
1.19) which demonstrated the ability of the CG scaffold to support human osteogenesis in 
vitro (Keogh et al. 2010). Whilst recent literature from our group has examined the effect of 
fluid flow on the behaviour of MC3T3 pre-osteoblast cells, we used a more clinically relevant 
cell line in this study as to date, the effects of fluid flow from a perfusion bioreactor on 
human cells within a CG scaffold have not been examined.  
In this study, a flow perfusion bioreactor that was developed in house and specifically 
designed for a compliant CG scaffold was used (Jaasma et al. 2008). CG scaffolds have been 
used successfully for skin and nerve regeneration and show potential as an excellent bone 
graft substitute (Compton et al. 1998; Tierney et al. 2008). They are a highly biocompatible 
and highly porous sponge made via a lyophilisation process and has been shown to support 
the growth and development of several cells types including mesenchymal stem cells (MSCs) 
and the cell lines mouse calvarial (MC3T3s) and hFOB (Farrell et al. 2006; Keogh et al. 
2010; Tierney et al. 2008). The use of the flow perfusion bioreactor was shown to be 
beneficial for osteogenesis by MC3T3 cells on the CG scaffold up to 28 days with increased 
levels of the mid stage marker osteopontin. However, it was also shown that longer term 
bioreactor culture (>24 hours) resulted in decreased cell numbers which was hypothesised to 
be attributed to flow-induced cellular detachment (Plunkett et al. 2010) . As a result, in the 
current study the flow regime is altered, and the duration of bioreactor culture reduced, with 
cell-seeded scaffolds subjected to a bioreactor culture regime of 3x1hour bouts of fluid flow 
in a 24 period prior to a static culture in osteogenic conditions up to 28 days.  The effects of 
this culture regime on cell distribution and osteogenesis by human cells is examined and 
compared to static culture conditions where cell-seeded scaffolds were not subjected to any 
period of bioreactor culture.  
The running hypothesis is that the use of the flow perfusion bioreactor will result in a 
more homogenous cell distribution within a CG scaffold by preventing peripheral 
encapsulation; this coupled with mechanical stimulation of the cells may provide an 
improved osteogenic response by the hFOB cells cultured on CG scaffolds.   
Materials and methods 
Bioreactor design 
A validated flow perfusion bioreactor system was used as described by Jaasma et al. 
(2008) (Fig.1). It consists of a syringe pump, a polycarbonate scaffold chamber and a media 
reservoir connected with gas permeable silicon tubing and quick release tubing connections 
(Cole-Parmer, Vernon Hills, IL). The bioreactor system was placed in a standard incubator. 
12.7 mm diameter scaffolds (with a thickness of 3.5 mm) were held in the scaffold chamber 
using silicone O-rings. The syringe pump held six 50ml syringes to allow simultaneous 
culture of 6 scaffolds per run.   
Scaffold fabrication 
Collagen-glycosaminoglycan (CG) scaffolds were fabricated using a lyophilisation 
technique as described previously (Haugh et al. 2010; O'Brien et al. 2005). Briefly, CG slurry 
was prepared by blending bovine collagen type-1 (0.5%wt) (Integra Life Sciences, 
Plainsboro, NJ) with 0.05M acetic acid (pH 3.2) containing shark cartilage derived 
chondroitin-6 sulfate (0.05%wt) (Sigma-Aldrich, Germany). After blending (Ultra turrax), 
the slurry was degassed prior to lyophilisation. The slurry was freeze dried at a cooling rate 
of 0.9oC/min with a final freezing temperature of -40oC at 50 mTorr for 24 hours. Scaffolds 
were then sterilized and cross-linked by a dehydrothermal treatment (DHT) by placing in a 
vacuum oven at 105oC for 24 hours (VacuCell 22). CG sheets (thickness = 3.5mm; mean 
pore diameter = 96µm; porosity = 99.5%) (Haugh et al. 2010; O'Brien et al. 2004) were 
aseptically cut to size (12.7 mmȈ). Scaffolds were further cross-linked with a filtered 
solution of 6mM solution of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDAC) and 
2mol N-hydroxysuccinimide (NHS) in distilled water for 2 hours at room temperature. 
Scaffolds were rinsed several times in sterile phosphate buffer solution (PBS) prior to cell 
seeding.   
Cell Culture, cell seeding and bioreactor conditions 
hFOB 1.19 human pre-osteoblastic cells were cultured under standard conditions (5% 
CO2, 37oC). Cells were routinely grown to 80% confluency in T175 culture flasks (Sarstedt, 
Ireland) containing a 1:1 ratio of HAMS F12 and DMEM (Gibco, UK), 10% FBS (Sigma-
Aldrich, UK), 2% penicillin/streptomycin (Sigma-Aldrich, UK), 1% G418 (Gibco, UK) and 
1% L-Glutamine (Sigma-Aldrich, UK).  
2x106 hFOB pre-osteoblasts were seeded dropwise on each side of the CG scaffolds (total 
of 4x106 cells per construct). Cell-seeded constructs were pre-cultured in standard media for 
6 days to allow for cell attachment, infiltration and proliferation (34oC optimal proliferation) 
(Donahue et al. 2000; Harris et al. 1995) Constructs were then placed in the flow perfusion 
bioreactor and exposed to 3 x 1hr bouts of steady flow (1ml/min) with each bout being 
followed by 7 hrs of no flow (to prevent cellular desensitization) for 25 hrs (bioreactor 
groups). Constructs in the bioreactor were cultured in standard media. Once removed from 
the bioreactor, the constructs were cultured statically in osteogenic conditions for a further 28 
days (39oC optimal differentiation). Osteogenic media consisted of standard media 
supplemented with 50µg/ml ascorbic acid, and 10mM β-glycerolphosphate, 10nM vitamin 
D3, 50nM vitamin K3, 10ng/ml transforming growth factor-β1 for 7 days, reduced to 0.2ng/ml 
thereafter (Sigma-Aldrich, UK). The static control group consisted of constructs that were 
placed in osteogenic media after the 6 day pre-culture period and maintained in static 
conditions in parallel with the bioreactor group. This group was not exposed to the bioreactor 
at any point and remained in static culture for the entire duration of the experiment. In 
addition, two other control groups were used; these were the ‘unseeded static’ and ‘unseeded 
bioreactor’ groups. These groups were cultured in identical conditions to the static and 
bioreactor groups except for the absence of cells. 
Viability of hFOB cells on CG scaffold 
Metabolic activity was analysed using the alamar blue assay. Media was removed and 
replenished with that containing 10% alamar blue dye (Bioscience, Ireland) at each end point. 
Scaffolds were incubated on an orbital shaker for 4 hours. 100µL of media was read using a 
spectrophotometer at 570nm and 610nm. The percentage of reduced dye was calculated in 
accordance with manufacturer’s recommendations.  
Cell number was assessed by measuring DNA content using the Hoechst 33258 DNA 
assay (Sigma-Aldrich, UK). Cell-seeded constructs were flash frozen in liquid nitrogen at 
each time point and stored at -80oC. DNA was isolated from the constructs by 
homogenisation in RLT lysis buffer (Qiagen, UK) using a rotor-stator homogeniser (Omni 
International, Germany). Cell lysates were centrifuged using QI Shredder columns (Qiagen, 
UK). Fluorescence was measured (excitation: 355 nm, emission: 460 nm; Wallac Victor2, 
PerkinElmer, Waltham, MA) on samples in triplicate and readings were converted to cell 
number using a standard curve. 
Histological staining for cell distribution on CG scaffold 
Tissue engineered constructs were fixed in 4% paraformaldehyde (Sigma-Aldrich, UK) 
for 30 minutes.  Dehydration and paraffin embedding was carried out using an automated 
tissue processor (ASP300, Leica) and cut into 10µm sections (RM2255, Leica). Standard 
haematoxylin & eosin staining was carried out on deparaffinised sections. Alizarin S Red 
staining for mineralisation was carried out using a 2% Alizarin red (Sigma-Aldrich, UK) 
solution for 2 minutes. Sections were rinsed several times with dH20, dehydrated in xylene 
and mounted with DPX. Images were captured on a digital microscope (NIS Elements, 
Nikon).  
Gene expression analysis  
RNA isolation: Cell seeded constructs were flash frozen in liquid nitrogen at each time 
point and stored at -80oC. RNA was isolated from the constructs by homogenisation in RLT 
lysis buffer (Qiagen, UK) using a rotor-stator homogeniser (Omni International, Germany). 
Cell lysates were centrifuged using QI Shredder columns (Qiagen, UK) and RNA extracted 
using the RNeasy Mini Kit (Qiagen, UK) according to the manufacturer’s instructions. RNA 
concentration was determined using a spectrophotometer at an absorbance of 260 nm. 
Following RNA extraction, Real time Reverse Transcription PCR was carried out for 
gene expression analysis. Trace genomic DNA was removed and RNA reverse transcribed 
using 400ng total RNA with an RT kit (QuantiTect RT Kit, Qiagen, UK) according to the 
manufacturer’s instructions. Real-time PCR was then carried out using the 7500 Real-Time 
PCR System (Applied Biosystems, UK). The QuantiTect SYBR Green PCR Kit (Qiagen, 
UK) was used, according to the manufacturer’s instructions, with QuantiTect Primers 
(Qiagen, UK). β-actin acted as a house keeping control and results were quantified for the 
early stage (alkaline phosphatase and osteonectin) and mid to late stage (osteopontin and 
osteocalcin) bone formation markers using the 2-∆∆Ct relative quantification method.  
Mechanical stiffness  
Mechanical stiffness of the tissue engineered scaffolds was analysed to determine if 
changes in cell/matrix distribution following bioreactor exposure caused variation in stiffness 
to that of static cultures. Stiffness of the constructs was determined using a Z050 mechanical 
testing machine (Z050, Zwick/Reoll) fitted with a 5-N load cell. Unconfined wet compression 
testing was performed on constructs that were immersed in PBS and tested at a rate of 10% 
strain/minute. The modulus was calculated from the slope of the stress-strain curve over the 
range 2-5% strain.   
Statistical analysis 
Statistical analysis was performed using sigma statistical software package SigmaStat 3.0. 
The statistical differences between 2 groups were calculated using the Students t test and 
multiple groups were calculated using Kruskal-Wallis One Way Analysis of Variance on 
Ranks (ANOVA). Statistical significance was declared at p<0.05. 
 
Results 
The number of hFOB cells increased up to 2x106 cells per scaffold by 21 days of culture 
in both the static and bioreactor groups with no significant difference observed between 
groups over time (Fig. 2a). Similarly, for both groups, metabolic activity was maintained over 
the culture duration, with no significant difference between the groups (Fig. 2b). 
Histological analysis showed that cells infiltrated the constructs over 28 days of culture in 
both the static and bioreactor groups (Fig. 3). However, differences in cell distribution were 
observed; cells in the constructs following bioreactor exposure appeared initially in clusters 
throughout the construct which increased in both number and distribution over time whereas 
cells on the static group resided predominantly along the scaffold periphery where by 14 days 
a cellular capsule had developed. Mineralisation reflected cell distribution where the greatest 
degree of staining was observed in the static groups but this mineralisation was found 
predominantly along the scaffold periphery (Fig. 4). Quantification of this revealed that the 
level of mineralisation was significantly greater in the static group than the bioreactor group 
(p<0.007). By day 28, levels of mineral were 3.8 fold higher in the static group compared to 
the bioreactor group (Fig. 5).    
Osteogenesis was supported in both static and bioreactor groups on the CG scaffold. Real 
time PCR showed that gene expression was altered in constructs following bioreactor culture 
compared to the statically cultured constructs (Fig. 6). A 3 fold increase in the expression of 
the early bone formation marker, alkaline phosphatase was seen in the bioreactor group 
versus the static group at 21 days. The mid stage markers osteopontin and osteonectin 
showed similar trends, with bioreactor groups providing higher expression levels earlier than 
the static groups; osteopontin expression increased by 1.6 fold after 1 day post-flow whereas 
the maximum expression levels of static groups occurred after 14 days. Similarly, osteonectin 
levels peaked after 14 days with a 1.7 fold increase for the bioreactor group (p<0.01) whereas 
the level of osteonectin in static cultures peaked later at 21 days. At this stage the levels of 
osteonectin were comparable in both groups. Expression levels of the late stage marker of 
bone formation, osteocalcin increased 2 fold after 1 day of bioreactor culture compared to 
constructs cultured statically (p<0.01). The levels of osteocalcin peaked at 21 days for both 
the static and bioreactor groups, but within that period, the expression levels increased 8 and 
12 fold (p<0.001) in static culture and bioreactor culture groups respectively.   
The compressive modulus of constructs in both the static and bioreactor groups increased 
with culture duration (Fig. 7). At the end of the 28 day culture period, the compressive 
modulus of constructs in the bioreactor group was 1.6 times greater than the statically 
cultured constructs. Also, an increase in stiffness was observed in cell-seeded constructs 
versus unseeded controls.  
 
Discussion 
 Long term static culture conditions can lead to a heterogeneous cell distribution, often 
resulting in the development of a peripheral cellular capsule which may result in the 
development of a necrotic/acellular central core caused by a reduction in mass transfer 
conditions (Partap et al. 2010). Bioreactors can improve mass transfer of nutrients and wastes 
via fluid flow and may also be used to encourage cell growth and maturation (Bjerre et al. 
2008; Yu et al. 2004). This study investigated the ability of a previously designed and 
validated flow perfusion bioreactor system (Jaasma et al. 2008) to enhance human hFOB cell 
distribution and osteogenic activity in a CG scaffold.  
Results of this study showed that just 3 hours of fluid flow culture prior to 28 days of 
static culture improved cell distribution and enhanced osteogenesis. Static and bioreactor 
groups displayed similar cell numbers and metabolic activity over time. The cell number was 
similar in the bioreactor and static groups using this flow regime of 3 hours whereas longer 
durations have shown a loss of cells following bioreactor culture (Jaasma and O'Brien 2008; 
Partap et al. 2009). However, histologically, there was a difference in cellular distribution 
between those constructs cultured statically or in the bioreactor. Constructs exposed to the 
bioreactor, displayed a more homogenous cell distribution throughout the construct compared 
to those cultured statically where the cells mainly resided along the construct periphery 
leading to peripheral encapsulation. In this study, static cultures developed peripheral 
encapsulation after 14 days in culture, a result that is consistent with other observations 
(Glowacki et al. 1998; Goldstein et al. 2001; Jaasma and O'Brien 2008; Janssen et al. 2006; 
Yu et al. 2004). The presence of a peripheral capsule can inhibit nutrient and waste mass 
transfer resulting in a necrotic core region. However, this was prevented by the use of the 
flow perfusion bioreactor which led to a redistribution of the cells. As a result of the spatial 
redistribution of the hFOB cells from the edge of the construct towards the centre due to fluid 
flow, the cells were visible in clusters throughout the constructs. Over time, these clusters 
became less evident (14 days post-flow) as a more homogenous cell distribution developed 
by the end of the culture period. Cells were evident in the centre of the construct by 21 days 
using the bioreactor but not until 28 days in static cultures. Therefore, it is clear that the short 
period of bioreactor culture (3 x 1 hr bouts) was beneficial for improving cell distribution 
within the construct. 
Levels of mineralization reflected cell distribution with greatest levels identified along the 
construct periphery of static cultures where cell aggregation occurred, a finding similar to 
previous reports using rat mesenchymal stem cells (Farrell et al. 2006). Although, 
significantly higher levels of mineralisation were found in the statically cultured constructs, 
this is not necessarily a negative indictment of the bioreactor. Even though it is of interest to 
produce large levels of calcified tissue, there is a need to produce a construct in vitro with 
homogenously distributed cells that express the desired genes for osteogenesis that will not 
restrict mass transfer in vivo after implantation into a defect. It is envisaged that the data 
collected from this study can be translated to other cell types such as mesenchymal stem 
cells. Interestingly, no significant decrease was seen in the biomechanical properties of the 
CG scaffold exposed to bioreactor culture when compared to constructs cultured under 
standard conditions. Thus, even though there was more mineral in the static groups, its poor 
distribution (predominantly along the construct periphery) did not manage to improve the 
mechanical properties. However, both sets of cell-seeded constructs were stiffer than the 
unseeded scaffolds demonstrating the improvement in mechanical properties as a result of 
cell-mediated matrix deposition and mineralisation.  
Gene expression analysis showed that exposing the constructs to just 3 hours of fluid flow 
in the bioreactor produced an altered pattern of gene expression compared to that observed in 
constructs cultured statically. The results show an increase in all early, mid and late stage 
bone formation markers investigated following bioreactor culture.  Importantly, the effects of 
mechanical stimulation on gene expression were still detected in the long term cultured 
constructs even after 28 days of bioreactor culture. Specifically, the levels of the early bone 
formation marker alkaline phosphatase increased over time with greatest expression levels 
observed at 21 days in the bioreactor group. The mid stage marker osteonectin showed 
similar trends between the static and bioreactor groups, its levels increased up to 21 days 
although greatest expression occurred at 14 days in the bioreactor groups (p<0.01). However, 
levels of osteopontin in the bioreactor groups increased following 3 hours of flow and 
declined thereafter. The late stage marker osteocalcin increased 8 fold in static cultures up to 
21 days, but greatest expression (1.3 fold higher) was observed in bioreactor groups (p<0.01). 
As the only difference between the culture groups was the effects of the bioreactor; the 
difference in gene expression levels appears to be due to the mechanostimulatory response 
provided by 3 hours of fluid flow prior to static culture, this mechanostimulatory response is 
particularly notable for OPN, where it is significantly upregulated after the application of 
flow. Whilst it is known that OPN is affected by a mechanical stimulus, its molecular 
mechanisms within the mechanotransduction pathways are still not completely understood.   
At present, the ideal flow regime to produce a viable construct in vitro has not yet been 
identified. In an attempt to find the ideal flow regime, the particular flow profile used in this 
study was based on a combination of the different flow regimes used in our group (Jaasma 
and O'Brien 2008; Plunkett et al. 2010). A limitation that we have previously reported is that 
constructs cultured in the bioreactor for prolonged periods exhibit flow-induced cellular 
detachment. Therefore, a significant finding of this study is that reducing culturing times 
within the bioreactor still elicits an osteogenic response and improves cellular homogeneity 
without significantly reducing cell numbers. This suggests that constructs do not need to be 
cultured continuously within a bioreactor for long periods of time. This is particularly 
important as long term bioreactor culture is often associated with being more time 
consuming, labour intensive and less cost effective than static culturing techniques. 
In conclusion, the flow perfusion bioreactor improved hFOB cell infiltration by 
discouraging peripheral encapsulation on CG scaffolds and induced a superior osteogenic 
response within the constructs under long term culture compared to static controls. Even 
though there was more mineral in the static groups, its poor distribution did not improve the 
mechanical properties of the constructs. Taking together the histological and gene expression 
results, this study demonstrates that just 3 hours of flow perfusion bioreactor culture prior to a 
28 day static culture period was beneficial for osteogenesis by human cells on a CG scaffold.  
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Fig. 1 Flow perfusion bioreactor for CG scaffolds. Reprinted from Journal of Biotechnology, 
133/4, Jaasma, M.J., N.A. Plunkett, and F.J. O'Brien, Design and validation of a dynamic 
flow perfusion bioreactor for use with compliant tissue engineering scaffolds, 490-6  
(2008), with permission from Elsevier. 
 
Fig. 2 Bioreactor and static culture cell number and metabolic activity of hFOB on CG 
scaffold. Similar levels of (a) cells numbers and (b) metabolic activity were observed at all 
time points in both static and bioreactor groups of hFOB cells on CG scaffold. Results are 
expressed as the mean ± standard deviation (n=5). 
 
Fig. 3 Histological analysis (H&E staining) of cell distribution within a CG scaffold; static 
control versus bioreactor culture over time. Cells attach to CG scaffolds and gradually 
infiltrate with time. Static groups develop a cellular capsule around the construct (white 
arrows) this; however, is prevented when using the bioreactor. 
 
Fig. 4 Alizarin red staining of CG constructs up to 28 days post bioreactor treatment. Staining 
reflected cell distribution found mineralisation in static groups predominantly at the scaffold 
edge (white arrows) following 14 days incubation. Lower levels of staining were observed in 
bioreactor treated groups. 
 
Fig. 5 A quantification of the levels of alizarin red staining. It was found that there was a 
significant increase in mineralisation in static groups compared to the bioreactor groups (* 
p<0.007). Results are expressed as the mean ± standard deviation (n=3). 
 Fig. 6 Gene expression results for static and bioreactor groups. Alkaline phosphatase 
expression levels in the bioreactor peaked at 21 days compared to the static group. 
Osteonectin levels increased up to 21 days for both the static and bioreactor groups and then 
decreased by day 28, however, osteonectin levels peaked earlier (by day 14) in the bioreactor 
group when compared to the same timepoint in the static group (*p<0.01). The greatest levels 
of osteopontin were observed at 1 day post bioreactor culture when compared to the same 
timepoint in the static group (*p<0.05). When compared to static culture, osteocalcin levels 
were significantly higher in the bioreactor groups at day 1 (*p<0.01) and by day 21 where a 
1.3 fold higher expression was observed (**p<0.01). Results are expressed as the mean ± 
standard deviation (n=5). 
 
Fig. 7 Biomechanical analysis cell free and cell seeded CG constructs following bioreactor 
and static culture up to 28 days. Cell seeded constructs were stiffer than unseeded scaffolds; 
however, no difference was observed between static or bioreactor groups. Results are 
expressed as the mean ± standard deviation (n=3). 
 
